David A Santos insider trades
Open-market stock purchases and sales by David A Santos, EVP, Chief Commercial Officer at Rigel Pharmaceuticals Inc, from SEC Form 4 filings since Aug 19, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | RIGL Rigel Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 1, 2026 | RIGL Rigel Pharmaceuticals Inc | Sold (not open market) | $26.1K |
| Feb 17, 2026 | RIGL Rigel Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 10, 2026 | RIGL Rigel Pharmaceuticals Inc | Sold (not open market) | $123K |
| Feb 2, 2026 | RIGL Rigel Pharmaceuticals Inc | Sold (not open market) | $206K |
Companies traded
- RIGL Rigel Pharmaceuticals Inc: 5 sales, last Jun 17, 2026